Stay updated with breaking news from Erici Richman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Rating) CEO Eric I. Richman acquired 4,000 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were purchased at an average cost of $2.71 per share, for a total transaction of $10,840.00. Following the completion of the acquisition, the chief executive officer now directly […]
Compounds reverse the neurodegenerative process observed in a Parkinson’s disease in vivo model Compounds are novel allosteric regulators that bind, stabilize and restore activity of mutated GCase Compounds decrease both phosphorylated and aggregated α -synuclein levels in vitro and in vivo BETHESDA, Md., May 03, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by using super-computational methods to target allosteric binding sites and guide enzymes back to their proper shape, today announced new pr...